Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Axsome Therapeutics (AXSM) stocks
Learn how to easily invest in Axsome Therapeutics stocks.
Axsome Therapeutics (AXSM) is a leading biotechnology business based in the US. It opened the day at $73.88 after a previous close of $74.12. During the day the price has varied from a low of $73.8 to a high of $76.5. The latest price was $74.82 (25 minute delay). Axsome Therapeutics is listed on the NASDAQ and employs 393 staff. All prices are listed in US Dollars.
How to buy Axsome Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – AXSM. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
CIBC Investor's Edge
- Easy to use platform
- Low fees
- Student and young investor discounts
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
What's in this guide?
- Can I buy shares in Axsome Therapeutics?
- Has coronavirus impacted Axsome Therapeutics shares?
- Axsome Therapeutics shares summary
- Compare share dealing platforms
- Is Axsome Therapeutics stock a buy or sell?
- Axsome Therapeutics performance over time
- Axsome Therapeutics's financials
- How volatile are Axsome Therapeutics shares?
- Does Axsome Therapeutics pay a dividend?
- Other common questions
Axsome Therapeutics stock price (NASDAQ:AXSM)Use our graph to track the performance of AXSM stocks over time.
Axsome Therapeutics shares at a glance
|52-week range||$20.63 - $82.85|
|50-day moving average||$69.61|
|200-day moving average||$63.57|
|Wall St. target price||$111.92|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-3.78|
Buy Axsome Therapeutics stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Axsome Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Axsome Therapeutics price performance over time
Historical closes compared with the close of $74.82 from 2023-06-02
|1 week (2023-05-30)||7.73%|
|1 month (2023-05-05)||1.46%|
|3 months (2023-03-06)||12.82%|
|6 months (2022-12-06)||-0.58%|
|1 year (2022-06-06)||188.10%|
|2 years (2021-06-03)||21.26%|
|3 years (2020-06-05)||77.38|
|5 years (2018-06-06)||1,978.33%|
Axsome Therapeutics financials
|Revenue TTM||$144.6 million|
|Gross profit TTM||$45.9 million|
|Return on assets TTM||-37.45%|
|Return on equity TTM||-250.92%|
|Market capitalisation||$3.2 billion|
TTM: trailing 12 months
Axsome Therapeutics share dividends
We're not expecting Axsome Therapeutics to pay a dividend over the next 12 months.
Axsome Therapeutics share price volatility
Over the last 12 months, Axsome Therapeutics's shares have ranged in value from as little as $20.63 up to $82.85. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Axsome Therapeutics's is 1.9004. This would suggest that Axsome Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Axsome Therapeutics overview
Axsome Therapeutics, Inc. , a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder; and Sunosi (solriamfetol), a medication indicated to the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea. It is also developing AXS-05, which is in Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation; AXS-07, an investigational medicine that has completed Phase III trials for the acute treatment of migraine; AXS-12, an investigational medicine, which is in Phase III trial to treat narcolepsy; AXS-14, a selective and potent norepinephrine reuptake inhibitor that is in Phase III trial for the treatment of fibromyalgia and other conditions; and solriamfetol, a dual-acting dopamine and norepinephrine reuptake inhibitor, which has completed a Phase 2 trial of for treating attention-deficit/hyperactivity disorder. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.
Stocks similar to Axsome Therapeutics
Axsome Therapeutics in the news
Axsome Therapeutics to Present New Sunosi® Data at SLEEP 2023
Axsome Therapeutics to Present New Sunosi® Data at SLEEP 2023
Axsome Therapeutics to Present Data and Post-Hoc Analyses on Auvelity® and Sunosi® at the 2023 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.Read more…
Best stock app for beginners for 2023
The best stock trading app for beginners is easy to use and offers free trades.Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.Read more…
More guides on Finder
Bad credit loans in Edmonton, Alberta
From personal and payday loans to lines of credit, compare loans for bad credit in Edmonton.
How to buy Sui (SUI) in Canada
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
How to buy Pepe (PEPE) in Canada
This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).
How to buy Arbitrum (ARB) in Canada
This guide provides step-by-step instructions on how to buy Arbitrum, lists some exchanges where you can get it and provides daily price data on (ARB).
How to buy SSV Network (SSV) in Canada
This guide provides step-by-step instructions on how to buy SSV Network, lists some exchanges where you can get it and provides daily price data on (SSV).
How to buy USDD (USDD) in Canada
This guide provides step-by-step instructions on how to buy USDD, lists some exchanges where you can get it and provides daily price data on (USDD).
How to buy Blur (BLUR) in Canada
This guide provides step-by-step instructions on how to buy Blur, lists some exchanges where you can get it and provides daily price data on (BLUR).
How to buy FLOKI Inu (FLOKI) in Canada
This guide provides step-by-step instructions on how to buy FLOKI Inu, lists some exchanges where you can get it and provides daily price data on (FLOKI).
How to buy Aptos (APT) in Canada
This guide provides step-by-step instructions on how to buy Aptos, lists some exchanges where you can get it and provides daily price data on (APT).
How to buy EthereumPoW (ETHW) in Canada
This guide provides step-by-step instructions on how to buy EthereumPoW, lists some exchanges where you can get it and provides daily price data on (ETHW).
Ask an Expert
You must be logged in to post a comment.